IL100631A - History of acridi, their preparation and pharmaceutical preparations containing them - Google Patents
History of acridi, their preparation and pharmaceutical preparations containing themInfo
- Publication number
- IL100631A IL100631A IL10063192A IL10063192A IL100631A IL 100631 A IL100631 A IL 100631A IL 10063192 A IL10063192 A IL 10063192A IL 10063192 A IL10063192 A IL 10063192A IL 100631 A IL100631 A IL 100631A
- Authority
- IL
- Israel
- Prior art keywords
- oxo
- dihydro
- acridinecarboxamide
- methyl
- phenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/07—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms
- C07C205/11—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms having nitro groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/13—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by hydroxy groups
- C07C205/26—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by hydroxy groups and being further substituted by halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/27—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups
- C07C205/35—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups having nitro groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
- C07C205/36—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups having nitro groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton to carbon atoms of the same non-condensed six-membered aromatic ring or to carbon atoms of six-membered aromatic rings being part of the same condensed ring system
- C07C205/37—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups having nitro groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton to carbon atoms of the same non-condensed six-membered aromatic ring or to carbon atoms of six-membered aromatic rings being part of the same condensed ring system the oxygen atom of at least one of the etherified hydroxy groups being further bound to an acyclic carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/49—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
- C07C205/56—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups bound to carbon atoms of six-membered aromatic rings and carboxyl groups bound to acyclic carbon atoms of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
- C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
- C07D219/06—Oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Plural Heterocyclic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Laminated Bodies (AREA)
- Soft Magnetic Materials (AREA)
- Paper (AREA)
- Dry Shavers And Clippers (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB919100637A GB9100637D0 (en) | 1991-01-11 | 1991-01-11 | Chemical compounds |
| GB919100628A GB9100628D0 (en) | 1991-01-11 | 1991-01-11 | Chemical compounds |
| GB919115981A GB9115981D0 (en) | 1991-07-24 | 1991-07-24 | Chemical compounds |
| GB919115956A GB9115956D0 (en) | 1991-07-24 | 1991-07-24 | Chemical compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL100631A0 IL100631A0 (en) | 1992-09-06 |
| IL100631A true IL100631A (en) | 1996-09-12 |
Family
ID=27450605
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL10063192A IL100631A (en) | 1991-01-11 | 1992-01-10 | History of acridi, their preparation and pharmaceutical preparations containing them |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US5604237A (no) |
| EP (2) | EP0569380B1 (no) |
| JP (1) | JP2783680B2 (no) |
| KR (1) | KR100220538B1 (no) |
| AT (1) | ATE153660T1 (no) |
| AU (1) | AU652996B2 (no) |
| CA (1) | CA2100258C (no) |
| CZ (1) | CZ283038B6 (no) |
| DE (1) | DE69220037T2 (no) |
| DK (1) | DK0569380T3 (no) |
| ES (1) | ES2104887T3 (no) |
| FI (1) | FI103888B (no) |
| GE (1) | GEP20002210B (no) |
| GR (1) | GR3024525T3 (no) |
| HU (2) | HUT68856A (no) |
| IE (1) | IE920083A1 (no) |
| IL (1) | IL100631A (no) |
| MX (1) | MX9200109A (no) |
| NO (1) | NO300267B1 (no) |
| NZ (1) | NZ241278A (no) |
| PL (1) | PL168202B1 (no) |
| RU (1) | RU2119482C1 (no) |
| SG (1) | SG45403A1 (no) |
| SK (1) | SK280864B6 (no) |
| WO (1) | WO1992012132A1 (no) |
Families Citing this family (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0569380B1 (en) * | 1991-01-11 | 1997-05-28 | Laboratoires Glaxo Sa | Acridine derivatives |
| GB9209872D0 (en) * | 1992-05-07 | 1992-06-24 | Ici Plc | Alkyl substituted nitrotoluene derivatives |
| TR28930A (tr) * | 1992-05-07 | 1997-07-21 | Zeneca Ltd | Alkil sübstitüentli nitrotoluen türevleri |
| AU4567193A (en) * | 1992-07-10 | 1994-01-31 | Laboratoires Glaxo S.A. | Anilide derivatives |
| RU2036198C1 (ru) * | 1993-04-01 | 1995-05-27 | Товарищество с ограниченной ответственностью "Полисан" | N-МЕТИЛ-N-( α,D -ГЛЮКОПИРАНОЗИЛ) АММОНИЯ-2-(АКРИДОН-9-ОН-10-ИЛ)АЦЕТАТ(ЦИКЛОФЕРОН), ОБЛАДАЮЩИЙ ИНТЕРФЕРОНОГЕННОЙ, ПРОТИВОВИРУСНОЙ, В ТОМ ЧИСЛЕ АНТИВИЧ, АНТИПАРАЗИТАРНОЙ, АНТИПРОМОТОРНОЙ И РАДИОПРОТЕКТИВНОЙ АКТИВНОСТЬЮ |
| US5387685A (en) * | 1993-07-16 | 1995-02-07 | American Cyanamid Co | MDR reversal agents |
| DE4422517A1 (de) * | 1994-06-28 | 1996-01-04 | Dresden Arzneimittel | Neue (2-(3,4-Dimethoxy-phenyl)-ethyl)-(2-phenoxy-ethyl)-amine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| CN1134410C (zh) * | 1994-08-04 | 2004-01-14 | C&C新药研究所 | 胺衍生物,制备它们的方法和它们作为抗心律失常药的应用 |
| AU702519B2 (en) * | 1994-10-05 | 1999-02-25 | Glaxo Wellcome Inc. | Parenteral pharmaceutical compositions containing GF120918A |
| FR2726267B1 (fr) * | 1994-10-26 | 1998-01-02 | Smithkline Beecham Lab | Nouveaux agents anti-arythmiques, compositions pharmaceutiques les contenant, et procede pour les preparer |
| US6245805B1 (en) | 1995-10-26 | 2001-06-12 | Baker Norton Pharmaceuticals, Inc. | Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents |
| US6395770B1 (en) | 1995-10-26 | 2002-05-28 | Baker Norton Pharmaceuticals, Inc. | Method and compositions for administering taxanes orally to human patients |
| AU1597197A (en) * | 1996-02-01 | 1997-08-22 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Thienoquinolines |
| US6713517B1 (en) | 1996-03-08 | 2004-03-30 | Oxigene, Inc. | Use of aryl N-substituted carboxamides directly and as radio-and chemosensitizers for killing tumor and cancer cells and novel compounds for such use |
| RU2118532C1 (ru) * | 1996-04-10 | 1998-09-10 | Олег Викторович Травкин | Противоинфекционное, противовоспалительное и противоопухолевое лекарственное средство |
| GB9708805D0 (en) | 1997-05-01 | 1997-06-25 | Smithkline Beecham Plc | Compounds |
| GB9710612D0 (en) * | 1997-05-23 | 1997-07-16 | Glaxo Group Ltd | Synthesis of acridine derivatives |
| KR100615783B1 (ko) * | 1997-05-27 | 2006-08-25 | 아이박스 리서치 인코포레이티드 | 탁산 치료를 받고 있는 인체를 제외한 포유동물의 과민증 또는 알러지 반응을 경감시키기 위한 방법 및 약학적 키트 |
| GB9718903D0 (en) * | 1997-09-05 | 1997-11-12 | Glaxo Group Ltd | Method,compositions and kits for increasing the oral bioavailability of pharmaceutical agents |
| GB9810876D0 (en) | 1998-05-20 | 1998-07-22 | Smithkline Beecham Plc | Compounds |
| GB9812189D0 (en) * | 1998-06-05 | 1998-08-05 | Glaxo Group Ltd | Methods and compositions for increasing penetration of HIV protease inhibitors |
| AU4698299A (en) * | 1998-06-30 | 2000-01-17 | Du Pont Pharmaceuticals Company | 5-HT7 receptor antagonists |
| KR20010085898A (ko) | 1998-10-08 | 2001-09-07 | 피터 기딩스 | 도파민 ｄ3 수용체 조절제 (정신병 치료제)로서 유용한테트라히드로벤즈아제핀 유도체 |
| DE60030283T2 (de) * | 1999-05-17 | 2007-09-20 | Cancer Research Ventures Ltd. | Zusammensetzungen zur erhöhung der bioverfügbarkeit von oral verabreichten pharmazeutischen verbindungen |
| AU775373B2 (en) | 1999-10-01 | 2004-07-29 | Immunogen, Inc. | Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents |
| US6521635B1 (en) | 2000-01-20 | 2003-02-18 | The United States Of America As Represented By The Department Of Health And Human Services | Inhibition of MXR transport by acridine derivatives |
| AU2001238499A1 (en) * | 2000-02-18 | 2001-08-27 | New York Medical College | Nitroacridine/tumor inhibitor compositions |
| KR20070087103A (ko) * | 2000-03-14 | 2007-08-27 | 액테리온 파마슈티칼 리미티드 | 1,2,3,4-테트라하이드로이소퀴놀린 유도체 |
| WO2001085693A1 (fr) | 2000-05-11 | 2001-11-15 | Banyu Pharmaceutical Co., Ltd. | Dérivés n-acyltétrahydroisoquinoline |
| WO2002032400A1 (en) * | 2000-10-16 | 2002-04-25 | Neopharm, Inc. | Liposomal formulation of mitoxantrone |
| AU2003233899B2 (en) * | 2002-05-14 | 2009-03-12 | Xenova Limited | Process for the preparation of a hydrate of an anthranilic acid derivative |
| WO2004039795A2 (en) * | 2002-10-29 | 2004-05-13 | Fujisawa Pharmaceutical Co., Ltd. | Amide compounds for the treatment of hyperlipidemia |
| EP1751111B1 (en) | 2004-03-01 | 2014-12-31 | Actelion Pharmaceuticals Ltd. | Substituted 1,2,3,4-tetrahydroisoquinoline derivatives |
| RU2346692C2 (ru) * | 2007-03-29 | 2009-02-20 | Ефаг АО | Применение 9-оксоакридин-10-уксусной кислоты, ее солей и сложных эфиров в комбинированной терапии рака яичников, способ лечения и наборы |
| SE531698C2 (sv) * | 2007-07-12 | 2009-07-07 | Respiratorius Ab | Nya bronkdilaterande a,b-omättade amider |
| WO2015142670A1 (en) * | 2014-03-15 | 2015-09-24 | Medisyn Technologies, Inc. | Anti-diabetic compounds, pharmaceutical compositions containing them, and method to treat diabetes |
| CN104434808A (zh) | 2014-07-03 | 2015-03-25 | 石药集团中奇制药技术（石家庄）有限公司 | 一种治疗性纳米粒子及其制备方法 |
| EP3768255A4 (en) * | 2018-03-21 | 2021-12-22 | Izumi Technology, LLC | DEUTERED ANALOGA OF ELACRIDAR |
| CN113387873B (zh) * | 2021-06-15 | 2022-09-20 | 山东第一医科大学(山东省医学科学院) | 取代二芳基类化合物其制备方法和用途 |
| CN115252613B (zh) * | 2022-08-09 | 2024-01-12 | 北京清华长庚医院 | 药物组合物及其在逆转仑伐替尼耐药性中的用途 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4250182A (en) * | 1972-02-24 | 1981-02-10 | Burroughs Wellcome Co. | Pharmaceutical composition containing acridone compounds and method of using same |
| US4021551A (en) * | 1972-06-07 | 1977-05-03 | Boehringer Ingelheim Gmbh | 3,6-Bis-(heterocyclic aminoacyl-amino)-acridines and salts thereof |
| US4127573A (en) * | 1972-09-06 | 1978-11-28 | Burroughs Wellcome Co. | Ditetrazole substituted acridone compounds |
| DE3170001D1 (en) * | 1980-09-30 | 1985-05-23 | Bayer Ag | Method for the production of an antithrombin-heparin complex and pharmaceutical compositions containing the complex |
| NZ198115A (en) * | 1981-08-21 | 1985-05-31 | New Zealand Dev Finance | 9-anilinoacridines;pharmaceutical compositions |
| NZ201084A (en) * | 1982-06-25 | 1985-10-11 | New Zealand Dev Finance | 4-carboxamidoacridine derivatives and pharmaceutical compositions containing such |
| IN164921B (no) * | 1986-07-22 | 1989-07-08 | Hoechst India | |
| US5104858A (en) * | 1988-09-29 | 1992-04-14 | Yale University | Sensitizing multidrug resistant cells to antitumor agents |
| CA1340821C (en) * | 1988-10-06 | 1999-11-16 | Nobuyuki Fukazawa | Heterocyclic compounds and anticancer-drug reinforcing agents containing them as effective components |
| JPH04506072A (ja) * | 1989-06-19 | 1992-10-22 | ザ・ウエルカム・ファウンデーション・リミテッド | 癌治療に有用であり、かつ抗ヒスタミン特性を有する医薬 |
| EP0569380B1 (en) * | 1991-01-11 | 1997-05-28 | Laboratoires Glaxo Sa | Acridine derivatives |
| US5296602A (en) * | 1991-03-18 | 1994-03-22 | Sloan-Kettering Institute For Cancer Research | Multisubstituted 1-hydroxy-9-acridones with anticancer activity |
| US5240936A (en) * | 1992-05-14 | 1993-08-31 | Texas A&M University System | Treating or preventing ocular inflammation or systemic imflammatory disease |
-
1992
- 1992-01-07 EP EP92901861A patent/EP0569380B1/en not_active Expired - Lifetime
- 1992-01-07 CZ CS931378A patent/CZ283038B6/cs not_active IP Right Cessation
- 1992-01-07 AT AT92901861T patent/ATE153660T1/de not_active IP Right Cessation
- 1992-01-07 SG SG1996006197A patent/SG45403A1/en unknown
- 1992-01-07 DK DK92901861.2T patent/DK0569380T3/da active
- 1992-01-07 ES ES92901861T patent/ES2104887T3/es not_active Expired - Lifetime
- 1992-01-07 PL PL92299989A patent/PL168202B1/pl unknown
- 1992-01-07 WO PCT/EP1992/000020 patent/WO1992012132A1/en active IP Right Grant
- 1992-01-07 HU HU9301989A patent/HUT68856A/hu unknown
- 1992-01-07 RU RU93051543A patent/RU2119482C1/ru active
- 1992-01-07 CA CA002100258A patent/CA2100258C/en not_active Expired - Lifetime
- 1992-01-07 AU AU11543/92A patent/AU652996B2/en not_active Expired
- 1992-01-07 SK SK730-93A patent/SK280864B6/sk not_active IP Right Cessation
- 1992-01-07 GE GEAP19922653A patent/GEP20002210B/en unknown
- 1992-01-07 EP EP92100123A patent/EP0494623A1/en active Pending
- 1992-01-07 DE DE69220037T patent/DE69220037T2/de not_active Expired - Lifetime
- 1992-01-07 KR KR1019930702079A patent/KR100220538B1/ko not_active IP Right Cessation
- 1992-01-07 JP JP4501671A patent/JP2783680B2/ja not_active Expired - Lifetime
- 1992-01-10 IL IL10063192A patent/IL100631A/en not_active IP Right Cessation
- 1992-01-10 NZ NZ241278A patent/NZ241278A/en not_active IP Right Cessation
- 1992-01-10 MX MX9200109A patent/MX9200109A/es unknown
- 1992-01-10 IE IE008392A patent/IE920083A1/en not_active IP Right Cessation
-
1993
- 1993-07-09 NO NO932512A patent/NO300267B1/no not_active IP Right Cessation
- 1993-07-09 FI FI933149A patent/FI103888B/fi active
-
1995
- 1995-06-06 US US08/468,620 patent/US5604237A/en not_active Expired - Lifetime
- 1995-06-29 HU HU95P/P00524P patent/HU211623A9/hu unknown
-
1997
- 1997-08-22 GR GR970402168T patent/GR3024525T3/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL100631A (en) | History of acridi, their preparation and pharmaceutical preparations containing them | |
| US5663179A (en) | Certain isoquinoline derivatives having anti-tumor properties | |
| EP0234872B1 (en) | Carboxamides useful as antiemetic or antipsychotic agents | |
| JPH06505025A (ja) | アシル補酵素ａ：コレステロールアシルトランスフェラーゼの阻害剤としての二環式アミド | |
| US20050014721A1 (en) | Novel compounds and a novel process for their preparation | |
| JP3341019B2 (ja) | 選択的ロイコトリエンｂ▲４▼拮抗剤活性を示す置換された単環式アリール化合物 | |
| CS228515B2 (en) | Method for producing new derivates of 6a,10a-trans-9beta-subst.-amino-1hydroxyoktahydrobenzo/c/quinoline | |
| US5889022A (en) | Indole, indoline and quinoline derivatives with 5HT1D (anti-depressive) activity | |
| JP3897363B2 (ja) | アルキルオキシアミノ置換フルオレノンおよびプロテインキナーゼｃ阻害剤としてのその使用 | |
| JP5529280B2 (ja) | 癌治療用のジ（フェニルプロパノイド）・グリセロール誘導体 | |
| JPS62234083A (ja) | 鎮吐薬または精神病治療薬として有用なカルボキサミド類 | |
| Nihei et al. | Synthesis of trypanocidal tetrahydrofuran lignans | |
| KR100542841B1 (ko) | 디알킬아미노알콕시기 치환된 플루오레논 및 이들의 단백질키나제c억제제로서의 용도 | |
| US6004959A (en) | Alkyloxyamino substituted fluorenones and their use as protein kinase-C inhibitors | |
| IE49997B1 (en) | Substituted-5-((7-chloro-4-quinolinyl)amino)-3-(aminomethyl)-(1,1'-biphenyl)-2-ol compounds;processes for their production;and pharmaceutical compositions containing the compounds | |
| KR100517582B1 (ko) | 디알킬아미노알콕시기 치환된 플루오레논 및 이들의 단백질키나제 ｃ 억제제로서의 용도 | |
| EP0579731A1 (en) | Disubstituted naphthalenes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| EXP | Patent expired |